EDGAR Filing Documents for 0001052918-21-000233

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001052918-21-000233

Filing Date

2021-06-23

Accepted

2021-06-23 16:54:49

Documents

Period of Report

2020-11-30

Document Format Files

Seq	Description	Document	Type	Size
1	AVRICORE HEALTH INC.	avricore6knov2020.htm	6-K	12597
2	EXHIBIT 99.1	nr_ex99z1.htm	EX-99.1	5881
3	EXHIBIT 99.2	mcr_ex99z2.htm	EX-99.2	12131
4	EXHIBIT 99.3	nr_ex99z3.htm	EX-99.3	12630
5	EXHIBIT 99.4	nr_ex99z4.htm	EX-99.4	6557
6	EXHIBIT 99.5	fs_ex99z5.htm	EX-99.5	275300
7	EXHIBIT 99.6	mda_ex99z6.htm	EX-99.6	114401
8	EXHIBIT 99.7	ceocert_ex99z7.htm	EX-99.7	6167
9	EXHIBIT 99.8	cfocert_ex99z8.htm	EX-99.8	6146
10	IMAGE	nrex99z1_1.jpg	GRAPHIC	7633
11	IMAGE	nrex99z3_1.jpg	GRAPHIC	5638
12	IMAGE	nrex99z4_1.jpg	GRAPHIC	5335
13	IMAGE	fsex99z5_1.jpg	GRAPHIC	6902
14	IMAGE	mdaex99z6_1.jpg	GRAPHIC	6902
	Complete submission text file	0001052918-21-000233.txt		498492

Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2

Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038

Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)